Search

Your search keyword '"MONLUN, Marie"' showing total 21 results
Start Over Author "MONLUN, Marie" Publisher american diabetes association
21 results on '"MONLUN, Marie"'

1. Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526

Author

Rigalleau, Vincent, primary, Larroumet, Alice, additional, Mohammedi, Kamel, additional, Baillet-Blanco, Laurence, additional, Monlun, Marie, additional, Delyfer, Marie-Noelle, additional, Korobelnik, Jean-François, additional, and Foussard, Ninon, additional

Published
2022
Full Text
View/download PDF

2. Comment on Sjöholm et al. Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-term Results From the Swedish Obese Subjects Study. Diabetes Care 2022;45:444–450

Author

Rigalleau, Vincent, primary, Barbet-Massin, Marie-Amélie, additional, Larroumet, Alice, additional, Mohammedi, Kamel, additional, Baillet-Blanco, Laurence, additional, Monlun, Marie, additional, Cherifi, Blandine, additional, and Foussard, Ninon, additional

Published
2022
Full Text
View/download PDF

5. Relationship between diabetic retinopathy stages and risk of major lower-extremity arterial disease in patients with type 2 diabetes

Author

Foussard, Ninon, primary, Saulnier, Pierre-Jean, primary, Potier, Louis, primary, Ragot, Stéphanie, primary, Schneider, Fabrice, primary, Gand, Elise, primary, Monlun, Marie, primary, Baillet-Blanco, Laurence, primary, Velho, Gilberto, primary, Marre, Michel, primary, Roussel, Ronan, primary, Rigalleau, Vincent, primary, Mohammedi, Kamel, primary, Hadjadj, Samy, primary, and Group, the SURDIAGENE Study, primary

Published
2020
Full Text
View/download PDF

8. Comment on Law et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815

Author

Foussard, Ninon, primary, Cambos, Sophie, additional, Poupon, Pauline, additional, Monlun, Marie, additional, Blanco, Laurence, additional, Haissaguerre, Magalie, additional, Grouthier, Virginie, additional, Velayoudom-Cephise, Fritz-Line, additional, Mohammedi, Kamel, additional, and Rigalleau, Vincent, additional

Published
2019
Full Text
View/download PDF

10. Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing. Diabetes Care 2019;42:576–584

Author

Stankevich, Lioubov, primary, Galhaud, Jean-Philippe, additional, Kuvshinov, Roman, additional, Helmer, Catherine, additional, Poupon, Pauline, additional, Blanco, Laurence, additional, Monlun, Marie, additional, Foussard, Ninon, additional, Mohammedi, Kamel, additional, and Rigalleau, Vincent, additional

Published
2019
Full Text
View/download PDF

11. Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes.

Author

Foussard, Ninon, Saulnier, Pierre-Jean, Potier, Louis, Ragot, Stéphanie, Schneider, Fabrice, Gand, Elise, Monlun, Marie, Baillet-Blanco, Laurence, Velho, Gilberto, Marre, Michel, Roussel, Ronan, Rigalleau, Vincent, Mohammedi, Kamel, Hadjadj, Samy, and SURDIAGENE Study Group

Subjects
DIABETIC retinopathy, TYPE 2 diabetes, ARTERIAL diseases, SYSTOLIC blood pressure, DIABETIC nephropathies, GLYCOSYLATED hemoglobin, PERIPHERAL vascular disease diagnosis, LEG surgery, DISEASE progression, PREDICTIVE tests, PERIPHERAL vascular diseases, PROGNOSIS, DISEASE incidence, LEG, AMPUTATION, DIABETIC angiopathies, LONGITUDINAL method, DISEASE complications
Abstract

Objective: We evaluated the association between diabetic retinopathy stages and lower-extremity arterial disease (LEAD), its prognostic value, and the influence of potential contributors to this relationship in a prospective cohort of patients with type 2 diabetes.Research Design and Methods: Diabetic retinopathy was staged at baseline as absent, nonproliferative, or proliferative. A Cox regression model was fitted in order to compute the hazard ratio (HR) (95% CI) for major LEAD (lower-limb amputation or revascularization) during follow-up by baseline retinopathy stages. The retinopathy-LEAD association was assessed in subgroups by age, sex, diabetes duration, HbA1c, systolic blood pressure, diabetic kidney disease, smoking, and macrovascular disease at baseline. The performance of retinopathy in stratifying LEAD risk was assessed by using the C statistic, integrated discrimination improvement (IDI), and net reclassification improvement (NRI).Results: Among 1,320 participants without a history of LEAD at baseline, 94 (7.1%) developed a major LEAD during a 7.1-year median follow-up (incidence rate 9.6 per 1,000 person-years [95% CI 7.8-11.7]). The LEAD incidence rate (per 1,000 person-years) increased as retinopathy worsened: it was 5.5 (95% CI 3.9-7.8) in participants in whom retinopathy was absent, 14.6 (11.1-19.3) in those with nonproliferative retinopathy, and 20.1 (11.1-36.3) in those with proliferative retinopathy. Nonproliferative retinopathy (adjusted HR 2.31 [95% CI 1.43-3.81], P = 0.0006) and proliferative retinopathy (3.14 [1.40-6.15], P = 0.007) remained associated with major LEAD. No heterogeneity was observed across subgroups. Retinopathy enhanced the C statistic (+0.023 [95% CI 0.003-0.044], P = 0.02), IDI (0.209 [0.130-0.321], P < 0.001), and NRI (0.562 [0.382-0.799], P < 0.001) values for risk of LEAD, beyond traditional risk factors.Conclusions: An independent dose-response relationship was identified between diabetic retinopathy stages and major LEAD. Retinopathy yielded incremental prognostic information for stratifying risk of LEAD, suggesting its usefulness as a predictor of LEAD. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

15. Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815–822

Author

Azar, Marie, primary, Coirier, Elise, additional, Delyfer, Marie-Noelle, additional, Korobelnik, Jean-François, additional, Mohammedi, Kamel, additional, Blanco, Laurence, additional, Alexandre, Laure, additional, Monlun, Marie, additional, and Rigalleau, Vincent, additional

Published
2018
Full Text
View/download PDF

19. Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing. Diabetes Care 2019;42:576-584.

Author

Stankevich, Lioubov, Galhaud, Jean-Philippe, Kuvshinov, Roman, Helmer, Catherine, Poupon, Pauline, Blanco, Laurence, Monlun, Marie, Foussard, Ninon, Mohammedi, Kamel, and Rigalleau, Vincent

Subjects
PREDIABETIC state, DIABETES, HEMOGLOBINS
Abstract

The authors comment on the study by Evron et al that evaluated the rate of use of HBA1c test as screening for prediabetes and diabetes done by the Labexa clinical laboratory group in New Aquitaine, France. They note that expanding use of HBA1c for screening diabetes led to 25% diagnosis of the condition. However, screening 21,102 people in a population of 6 million is not considered sufficient action for public health.

Published
2019
Full Text
View/download PDF

20. Comment on Pongrac Barlovic et al. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up. Diabetes Care 2018;41:2487-2494.

Author

Camoin, Marion, Delyfer, Marie-Noelle, Korobelnik, Jean-François, Mohammedi, Kamel, Blanco, Laurence, Foussard, Ninon, Poupon, Pauline, Monlun, Marie, Haissaguerre, Magalie, and Rigalleau, Vincent

Subjects
TYPE 1 diabetes, RETROLENTAL fibroplasia, DIABETIC retinopathy, DIABETES, DIABETIC nephropathies
Abstract

The article comments on a study related to the association of severe diabetic retinopathy (SDR) with cardiovascular outcomes in long-standing type 1 diabetes. It notes that SDR predisposes to foot ulcers and amputations in type 1 diabetes, it is suggested that this association may be mediated by more diabetic peripheral neuropathy.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results